Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 13
Submit an article Journal homepage
524
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Late-onset complications with bendamustine versus CHOP or CVP based chemoimmunotherapy in indolent Non-Hodgkin’s lymphoma

Grace T. Baeka Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI, USA
,
Noah J. Mathisb Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
,
Anthony J. Perissinottia Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI, USA;c College of Pharmacy, University of Michigan, Ann Arbor, MI, USA
,
Bernard L. Marinia Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI, USA;c College of Pharmacy, University of Michigan, Ann Arbor, MI, USA
,
Anna Browna Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI, USA;c College of Pharmacy, University of Michigan, Ann Arbor, MI, USA
,
Tycel J. Phillipsd Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USA
,
Ryan A. Wilcoxd Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USA
&
Victoria R. Nachara Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI, USA;c College of Pharmacy, University of Michigan, Ann Arbor, MI, USACorrespondence[email protected]
 show all
Pages 3138-3146 | Received 14 Jan 2021, Accepted 30 Jun 2021, Published online: 15 Jul 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Salvatore Perrone, Paolo Lopedote, Mario Levis, Alice Di Rocco & Stephen Douglas Smith. (2022) Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy. Expert Review of Hematology 15:3, pages 215-232.
Read now

Articles from other publishers (1)

Ramon Diez-Feijóo, Juan Jose Rodríguez-Sevilla, Concepcion Fernández-Rodríguez, Solange Flores, Carmen Raya, Ana Ferrer, Luis Colomo & Antonio Salar. (2022) Case Report: High Doses of Intravenous Immunoglobulins as a Successful Treatment for Late Onset Immune Agranulocytosis After Rituximab Plus Bendamustine. Frontiers in Immunology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.